New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:46 EDTNBSNeoStem begins research collaboration for Scleroderma skin wound treatment
NeoStem announced that it has signed an agreement for a research collaboration investigating the potential of very small embryonic-like stem cells, or VSELs, in treating difficult to heal wounds in an animal model of scleroderma. The collaboration is funded in part by a previously announced $147,765 grant from the Small Business Innovative Research Program for the "Development of Adult Pluripotent Very Small Embryonic Like Stem Cells to Treat Skin Wounds in Scleroderma" from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, or NIH-NIAMS. The study will employ the tight skin mouse to test the potential wound healing capabilities of autologous VSELs in treating difficult to heal skin ulcers characteristic of this disease. Depending on the results of the study, the company may qualify for up to an additional $1.5M phase 2 grant for the indication from NIH-NIAMS.
News For NBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
06:05 EDTNBSBioLife Solutions biopreservation products used at Progenitor Cell Therapy
BioLife Solutions (BLFS) provided an update on use of the company's HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media by Progenitor Cell Therapy, or PCT, a wholly owned subsidiary of NeoStem (NBS) a leader in the emerging cellular therapy field.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use